Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 4

1(25.0%)

4Total

N/A(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06688825Not ApplicableRecruiting

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

Role: collaborator

NCT00399880Not ApplicableCompleted

Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes

Role: collaborator

NCT00577499Terminated

Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis

Role: collaborator

NCT00203476Phase 4Completed

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

Role: collaborator

NCT01427218Not ApplicableUnknown

Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease

Role: collaborator

All 5 trials loaded